Your browser doesn't support javascript.
loading
Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.
Servaas, Nila H; Hiddingh, Sanne; Chouri, Eleni; Wichers, Catharina G K; Affandi, Alsya J; Ottria, Andrea; Bekker, Cornelis P J; Cossu, Marta; Silva-Cardoso, Sandra C; van der Kroef, Maarten; Hinrichs, Anneline C; Carvalheiro, Tiago; Vazirpanah, Nadia; Beretta, Lorenzo; Rossato, Marzia; Bonte-Mineur, Femke; Radstake, Timothy R D J; Kuiper, Jonas J W; Boes, Marianne; Pandit, Aridaman.
Afiliação
  • Servaas NH; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Hiddingh S; Center for Translational Immunology and Ophthalmo-Immunology Unit, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Chouri E; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Wichers CGK; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Affandi AJ; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Ottria A; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Bekker CPJ; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Cossu M; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Silva-Cardoso SC; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • van der Kroef M; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Hinrichs AC; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Carvalheiro T; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Vazirpanah N; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Beretta L; Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Rossato M; Department of Biotechnology, University of Verona, Verona, Italy.
  • Bonte-Mineur F; Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, The Netherlands.
  • Radstake TRDJ; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Kuiper JJW; Center for Translational Immunology and Ophthalmo-Immunology Unit, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Boes M; Department of Pediatrics, University Medical Center Utrecht, Utrecht University, The Netherlands.
  • Pandit A; Center for Translational Immunology and Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Arthritis Rheumatol ; 75(2): 279-292, 2023 02.
Article em En | MEDLINE | ID: mdl-36482877
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article